Sanovas said yesterday it launched another subsidiary, SteriView, along with its SteriView instrument inspection and infection control system.
The newly launched system is designed as a “front line solution” against hospital-acquired infections, Sausalito, Calif.-based Sanovas said. The system allows direct visual inspection and cleaning of hard to reach spaces on endoscopes and medical instruments.
“Healthcare-acquired infections impact millions of people, worldwide. The SteriView instrument inspection and infection control system, featuring the SteriCam line of inspection cameras, represents the next inventive step in the infection control process and comprises a most critical asset in the fight against healthcare-acquired, device-related infections. These infections kill over 75,000 people every year in the U.S. and are estimated to cost $20 to $35 billion in excess healthcare costs and up to $35 billion in lost productivity, annually, in the United States alone. SteriView will positively impact the lives of patients throughout the US and across the world,” Sanovas CEO Larry Gerrans said in a press release.
Sanovas said it has placed over $1 million worth of SteriView instrument inspection and infection control systems during the pilot phase of the device, and a major outcomes study of the device is slated to be published in spring next year.
“Direct field experience, plus the weight of formally conducted studies, point to an undiscovered territory of deficiencies inside medical and surgical instrumentation, not adequately addressed by current reprocessing methods and their control procedures. The ability to see inside these instruments represents a leap forward – it is the mission of SteriView Inc. to bring that ability to clinicians worldwide, to make a positive impact through reductions in procedures related mobility and mortality,” Sanovas clinical affairs & education VP Mike Humason said in prepared remarks.
Just last week, Sanovas announced the launch of another subsidiary, SinuGeniX, focused on treating chronic sinusitis with the company’s RegENT sinus treatment system.
The newly-launched subsidiary won’t just supply a single tool for treating chronic sinusitis, which affects over 28 million Americans, but a suite of technologies, Sanovas CEO and system co-inventer Larry Gerrans told MassDevice.com in an interview.
“I wanted to create the tool belt, not just the tool. We’ve created a number of very complimentary tools that will improve physicians access and imaging along with the treatment procedure and measurement. It runs with the theme which I’ve always had, which is that you have to AIM – access, image and measure. Then you have the ability to perform diagnostics and treatment,” Gerrans said.